The Cannabis Tax Revolt: Why 280E Is Breaking the Legal Market

Understanding Section 280E

Section 280E of the Internal Revenue Code is a single sentence with devastating impact:

"No deduction or credit shall be allowed for any amount paid or incurred during the taxable year in carrying on any trade or business if such trade or business (or the activities which comprise such trade or business) consists of trafficking in controlled substances (within the meaning of schedule I and II of the Controlled Substances Act) which is prohibited by Federal law or the law of any State in which such trade or business is conducted."

Enacted in 1982 to prevent drug traffickers from deducting business expenses, 280E was never intended for state-legal businesses. ^[1] But because cannabis remains a Schedule I controlled substance under federal law, the IRS interprets every state-legal cannabis business as "trafficking in controlled substances."

The Financial Impact

Under 280E, cannabis businesses cannot deduct ordinary operating expenses that every other business in America writes off:

• Payroll and employee benefits
• Rent and utilities
• Marketing and advertising
• Professional services (legal, accounting)
• Insurance
• Office supplies and equipment

The only deductions permitted are cost of goods sold (COGS)—direct costs tied to product inventory. Everything else is taxed as if it were profit. ^[2]

This isn't theoretical. Industry analysis confirms that 280E pushes effective tax rates to 70% or higher for most operators. ^[2] For small dispensaries operating on thin margins, this tax structure is existential.

The Rescheduling Stalemate

The only administrative remedy for 280E is rescheduling cannabis from Schedule I to Schedule III. Schedule III substances—including ketamine and anabolic steroids—are recognized as having accepted medical uses. ^[3]

Moving to Schedule III would instantly eliminate 280E applicability, allowing cannabis businesses to deduct normal operating expenses. This single change would transform industry financial health more than any other federal action.

The Current Status: Indefinite Limbo

The rescheduling process has stalled at a critical juncture:

The postponement means rescheduling remains "in limbo" as of December 2025, with no clear timeline for when the administrative process will resume or conclude. ^[1]

The Tax Revolt

Faced with unsustainable tax burdens and indefinite administrative delays, a growing number of cannabis operators are taking direct action: aggressively challenging their federal tax obligations.

This "cannabis tax revolt" involves businesses filing returns that dispute the amounts owed under 280E, often arguing that state-legal operations should not be treated as criminal trafficking enterprises. ^[2]

Legal Strategies

The revolt employs several approaches:

• Constitutional challenges: Arguing 280E violates equal protection or due process when applied to state-legal businesses
• COGS maximization: Aggressively interpreting which costs qualify as deductible "cost of goods sold"
• Tax Court appeals: Forcing the IRS to defend assessments in formal legal proceedings
• Delayed payment: Withholding disputed amounts pending resolution

The Risks

This strategy is not without danger. The IRS has full enforcement authority, including:

• Penalties and interest: Accumulating on unpaid amounts
• Audits: Increased scrutiny of cannabis businesses filing disputed returns
• Liens and levies: Asset seizure to recover unpaid taxes
• Criminal prosecution: In extreme cases of willful tax evasion

But for operators facing insolvency under current tax burdens, the calculus is existential: fight and possibly survive, or comply and definitely fail.

Congressional Paralysis

While the administrative rescheduling process stalls, legislative reform remains equally gridlocked. The Cannabis Administration and Opportunity Act (CAOA)—which would remove marijuana entirely from the Controlled Substances Act—has been reintroduced multiple times but never advances beyond committee. ^[4]

Following its May 2024 reintroduction, the CAOA was referred to the Committee on Finance, where "no recent action has been taken". ^[5] The bill's persistent failure reflects deep political division on cannabis policy despite strong public support for legalization.

State Success vs. Federal Failure

The 280E crisis is particularly absurd given the proven success of state-legal markets:

• Ohio: $702.5M in first-year recreational sales ^[6]
• New York: $1.4B total, 522 dispensaries ^[7]
• California: $141M in Q1 2025 excise tax alone ^[8]

These markets demonstrate consumer demand, generate tax revenue, and successfully transition consumers from illicit to regulated sources. Yet federal policy treats every operator in these legal markets as a criminal enterprise for tax purposes.

Industry Perspectives

Cannabis industry advocates emphasize that 280E relief would be transformative. Financial advisors note that eliminating the tax burden would allow operators to "reinvest in their people, their technology, and their communities instead of just sending it all to the IRS". ^[2]

The Marijuana Policy Project describes Schedule III rescheduling as a "major breakthrough" that would acknowledge cannabis's medical value and increase pressure on Congress for broader reform. ^[3]

What Happens Next?

The industry's near-term future hinges on two parallel tracks:

1. Administrative Rescheduling

Resolution of the DEA's stalled administrative process remains the fastest path to 280E relief. But with no timeline for the postponed hearing, operators face continued uncertainty.

2. The Tax Revolt's Legal Test

As more businesses file disputed returns, the IRS will eventually be forced to respond—either through enforcement actions or by seeking clarity from Tax Court. These cases could establish precedent for how 280E applies to state-legal operations.

3. Congressional Long Shot

Comprehensive legislative reform (CAOA, SAFE Banking) remains politically unlikely in the near term despite strong public support. Meaningful change via Congress appears years away.

Risks and Opportunities

Conclusion

Section 280E represents the single greatest structural barrier to cannabis industry success. By treating state-legal businesses as criminal trafficking enterprises for tax purposes, federal policy creates unsustainable financial pressure that drains capital, prevents reinvestment, and undermines the legal market's ability to compete with illicit alternatives.

The cannabis tax revolt reflects industry desperation—operators willing to risk IRS enforcement because the alternative is certain failure under current tax burdens. Whether this strategy succeeds in forcing policy change or simply results in increased enforcement remains to be seen.

Meanwhile, the DEA's indefinitely postponed rescheduling hearing leaves the industry in limbo. State markets continue proving the model works. Consumer demand remains strong. But until federal policy catches up to reality, every cannabis business in America operates with one hand tied behind its back—forced to send the majority of its revenue to the IRS rather than investing in growth, employees, or communities.

---